Pyrazolo[1,5-a]pyridine-7-carbaldehyde, 95.0%, 100mg

6-Iodo-1H-benzo[d]imidazole, 95.0%, 1g

Ethyl 4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxylate, 95.0%, 1g

METHYL 4-BROMOPYRIDINE-2-CARBOXYLATE HYDROBROMIDE, 95.0%, 5g

(S)-a-(Fmoc-amino)-3,5-difluorobenzenebutanoic acid, 95%, 50mg

1-Methoxypyrene, 95.0%, 5g

2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetic acid, 95.0%, 1g

7-Methyl-1,8-naphthyridin-2-amine, 95.0%, 250mg

Diethyl Oxalacetate>95.0%(GC)5g

4,5-Dichloro-2-ethylpyridazin-3(2H)-one, 95%, 100mg

Trietanolamina, 10 l

n-Heptano, ROTISOLV® al menos 95 %, HPLC, 2,5 l, envase de vidrio

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 500m2/g)5g